Nisaurrahmah N, Sri O, Ifora I. Efficacy and Safety of 5-Hydroxytryptamine-3 Receptor Antagonists (5-HT3 RAs) for The Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: A Review. J. Drug Delivery Ther. 2021;11(1-s):195-199. doi:10.22270/jddt.v11i1-s.4554